Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
303
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Wuxi Biologics
•
16 Jul 2020 10:21
Wuxi Biologics - Recap/Learnings from past Placements
Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...
Sumeet Singh
Follow
473 Views
Share
bullish
•
SK Biopharmaceuticals
•
02 Jul 2020 00:03
Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing
Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...
Ken S. Kim
Follow
356 Views
Share
bullish
•
Wuxi Biologics
•
29 Jun 2020 18:42
Wuxi Biologics Placement - This Time It's Different
Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...
Sumeet Singh
Follow
453 Views
Share
bearish
•
Quantitative Analysis
•
29 Jun 2020 16:29
Asia Short Interest Weekly - Big Jump in Japan Shorts
The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...
Brian Freitas
Follow
293 Views
Share
bullish
•
Samsung C&T
•
15 Jun 2020 06:26
Korea Synthetic Stubs: C&T at 2-Yr Low, Pure Stub Trade with Biologics
Out of the five synthetic stubs in Korea, two names are in a severe diversion at this point.They are Samsung C&T and CJ Corp.C&T is now at...
Sanghyun Park
Follow
277 Views
Share
First
Previous
27
28
29
30
31
32
33
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x